TY - JOUR
T1 - Loss of function variants in L2HGDH gene causing l-2-hydroxyglutaric aciduria
AU - Bellad, Anikha
AU - Holla, Vikram V.
AU - Kumari, Riyanka
AU - Kamble, Nitish
AU - Yadav, Ravi
AU - Pandey, Akhilesh
AU - Pal, Pramod Kumar
AU - Muthusamy, Babylakshmi
N1 - Publisher Copyright:
© 2023, The Author(s) under exclusive licence to Belgian Neurological Society.
PY - 2023/12
Y1 - 2023/12
N2 - Background: l-2-Hydroxyglutaric aciduria (L2HGA) is a rare progressive neurometabolic disorder with variable clinical presentation including cerebellar ataxia, psychomotor retardation, seizures, macrocephaly and speech problems. In this study, we aimed at identifying the genetic cause in two unrelated families suspected with L2HGA. Methods: Exome sequencing was performed on two patients from family 1 with suspected L2HGA. MLPA analysis was carried out on the index patient of family 2 to detect deletions/duplications in the L2HGDH gene. Sanger sequencing was carried out to validate the identified variants and to confirm segregation of the variants in the family members. Results: In family 1, a novel homozygous variant c.1156C > T resulting in a nonsense mutation p.Gln386Ter was identified in the L2HGDH gene. The variant segregated with autosomal recessive inheritance in the family. In family 2, a homozygous deletion of exon 10 in the L2HGDH gene was identified in the index patient using MLPA analysis. PCR validation confirmed the presence of the deletion variant in the patient which is not present in the unaffected mother or an unrelated control. Conclusion: This study identified novel pathogenic variants in the L2HGDH gene in patients with L2HGA. These findings contribute to the understanding of the genetic basis of L2HGA and highlight the importance of genetic testing for diagnosis and genetic counseling of affected families.
AB - Background: l-2-Hydroxyglutaric aciduria (L2HGA) is a rare progressive neurometabolic disorder with variable clinical presentation including cerebellar ataxia, psychomotor retardation, seizures, macrocephaly and speech problems. In this study, we aimed at identifying the genetic cause in two unrelated families suspected with L2HGA. Methods: Exome sequencing was performed on two patients from family 1 with suspected L2HGA. MLPA analysis was carried out on the index patient of family 2 to detect deletions/duplications in the L2HGDH gene. Sanger sequencing was carried out to validate the identified variants and to confirm segregation of the variants in the family members. Results: In family 1, a novel homozygous variant c.1156C > T resulting in a nonsense mutation p.Gln386Ter was identified in the L2HGDH gene. The variant segregated with autosomal recessive inheritance in the family. In family 2, a homozygous deletion of exon 10 in the L2HGDH gene was identified in the index patient using MLPA analysis. PCR validation confirmed the presence of the deletion variant in the patient which is not present in the unaffected mother or an unrelated control. Conclusion: This study identified novel pathogenic variants in the L2HGDH gene in patients with L2HGA. These findings contribute to the understanding of the genetic basis of L2HGA and highlight the importance of genetic testing for diagnosis and genetic counseling of affected families.
KW - Intellectual disability
KW - Metabolic disorders
KW - Mitochondrial enzymes
KW - l-2-Hydroxyglutaric aciduria
UR - http://www.scopus.com/inward/record.url?scp=85163346334&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85163346334&partnerID=8YFLogxK
U2 - 10.1007/s13760-023-02318-7
DO - 10.1007/s13760-023-02318-7
M3 - Article
C2 - 37378753
AN - SCOPUS:85163346334
SN - 0300-9009
VL - 123
SP - 2315
EP - 2323
JO - Acta Neurologica Belgica
JF - Acta Neurologica Belgica
IS - 6
ER -